Different outcome of invasive cervical cancer associated with high‐risk versus intermediate‐risk HPV genotype

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Cancer

• Publication date

  2009-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.24075PMID 19035459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution Study

  2008cited by this paper
• Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

  2007cited by this paper
• Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.

  2007cited by this paper
• Evaluation of the SPF10-INNO LiPA Human Papillomavirus (HPV) Genotyping Test and the Roche Linear Array HPV Genotyping Test

  2006cited by this paper
• Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.

  2006cited by this paper
• MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors

  2006cited by this paper
• Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma

  2005cited by this paper
• Comparison of Two Commercial Assays for Detection of Human Papillomavirus (HPV) in Cervical Scrape Specimens: Validation of the Roche AMPLICOR HPV Test as a Means To Screen for HPV Genotypes Associated with a Higher Risk of Cervical Disorders

  2005cited by this paper
• Classification of papillomaviruses.

  2004cited by this paper
• HPV‐DNA, vascular space invasion, and their impact on the clinical outcome in early‐stage cervical carcinomas

  2004cited by this paper
• Human papillomavirus‐31‐related types predict better survival in cervical carcinoma

  2004cited by this paper
• Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion.

  2003cited by this paper
• Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy.

  2002cited by this paper
• The causal relation between human papillomavirus and cervical cancer.

  2002cited by this paper
• Papillomaviruses and cancer: from basic studies to clinical application

  2002cited by this paper
• Clinical and Prognostic Significance of Human Papillomavirus in a Chinese Population of Cervical Cancers

  2001cited by this paper
• Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.

  2001cited by this paper
• The presence of HPV DNA in cervical cancer: Correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University

  2000cited by this paper
• Surgery, gynecology & obstetrics. Journal of the American College of Surgeons.

  2000cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999cited by this paper
• Do HPV‐negative cervical carcinomas exist?—revisited

  1999cited by this paper
• Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types

  1999cited by this paper
• Human papillomavirus genotype as a major determinant of the course of cervical cancer.

  1998cited by this paper
• Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.

  1997cited by this paper
• Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.

  1997cited by this paper
• Polymerase chain reaction compared with dot blotting for the determination of N‐myc gene amplification in neuroblastoma

  1997cited by this paper
• Type of human papillomavirus is related to clinical features of cervical carcinoma

  1996cited by this paper
• Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

  1995cited by this paper
• Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer.

  1995cited by this paper
• Human papillomavirus in cell samples from Stockholm Gynecologic Health Screening.

  1995cited by this paper
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

  1995cited by this paper
• The genotypes and prognostic significance of human papillomaviruses in cervical cancer

  1994cited by this paper
• HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer.

  1993cited by this paper
• Human papillomavirus infection of the cervix; Relative risk associations of 15 common anogenital types

  1992cited by this paper
• Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer.

  1992cited by this paper
• Human papillomavirus and its prognostic significance in invasive carcinoma of the cervix in young patients.

  1992cited by this paper
• Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA.

  1991cited by this paper
• Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA.

  1990cited by this paper
• Human Papillomavirus Genotype as a Prognostic Indicator in Carcinoma of the Uterine Cervix

  1989cited by this paper
• Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix

  1989cited by this paper
• Notions générales sur le réticulosarcome des ganglions lymphatiques et des formations lymphoïdes

  1949cited by this paper

• Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial

  2025cites this paper
• Molecular Features of HPV-Independent Cervical Cancers

  2025cites this paper
• HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas

  2025cites this paper
• Consensus virtual screening to propose antivirals from Myrtus communis L. against human papillomavirus: Machine learning and docking

  2025cites this paper
• Research progress on human papillomavirus-negative cervical cancer: A review

  2024cites this paper
• HPV DNA Integration at Actionable Cancer-Related Genes Loci in HPV-Associated Carcinomas

  2024cites this paper
• Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts

  2024cites this paper
• Tumor human papillomavirus: a potential test for cervical cancer prognosis

  2023cites this paper
• Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

  2023cites this paper
• Prediction of carcinogenic human papillomavirus types in cervical cancer from multiparametric magnetic resonance images with machine learning-based radiomics models

  2022cites this paper
• The functions of lncRNAs in the HPV-negative cervical cancer compared with HPV-positive cervical cancer

  2022cites this paper
• Infection status and survival impact of high-risk human papillomavirus in cervical adenocarcinomas: A systematic review and meta-analysis.

  2022cites this paper
• The Prognostic Values of HPV Genotypes and Tumor PD-L1 Expression in Patients With HPV-associated Endocervical Adenocarcinoma

  2021cites this paper
• HPV and lung cancer: A systematic review and meta‐analysis

  2021cites this paper
• High prevalence of mixed and non-vaccine HPV oncogenic types and their association with higher mortality in Black women with cervical cancer

  2021cites this paper
• Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer

  2021cites this paper
• Comprehensive Identification of the Human Secretome as Potential Indicators in Treatment Outcome of HPV-Positive and -Negative Cervical Cancer Patients

  2020cites this paper
• Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor Markers

  2020cites this paper
• Identification of Specific Tumor Markers in Vulvar Carcinoma Through Extensive Human Papillomavirus DNA Characterization Using Next Generation Sequencing Method.

  2020cites this paper
• Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients

  2020cites this paper
• Correlation of interleukin-18 gene polymorphism with the susceptibility of condyloma acuminatum in Chinese population

  2019cites this paper
• [Circulating tumor DNA assessment for gynaecological cancers management].

  2019cites this paper
• HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report

  2019cites this paper
• Prevalence and distribution of high risk human papillomavirus subtypes in invasive cervical cancer in South-West Nigeria

  2018cites this paper
• Low Necroptosis Process Predicts Poor Treatment Outcome of Human Papillomavirus Positive Cervical Cancers by Decreasing Tumor-Associated Macrophages M1 Polarization

  2018cites this paper
• A Case of Human Papilloma Virus 31- and 68-Associated Metastatic Squamous Cell Carcinoma of the Cervix in a Healthy 28-Year-Old Woman

  2018cites this paper
• Nuclear factor I X is a recurrent target for HPV16 insertions in anal carcinomas

  2018cites this paper
• Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan

  2018cites this paper
• Discriminating Performance of Early Uterine and Cervical Artery Pulsatility and Resistivity In Pre-Invasive Cervical Lesions

  2018cites this paper
• Population-Based Assessment of HPV Genotype-Specific Cervical Cancer Survival: CDC Cancer Registry Sentinel Surveillance System

  2018influential citation
• Prevalence and Distribution of High-Risk Human Papillomavirus Genotypes in Invasive Carcinoma of the Uterine Cervix in Uruguay. An update on clinical outcome

  2017cites this paper
• Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis

  2017cites this paper
• Mechanistic signatures of HPV insertions in cervical carcinomas

  2016cites this paper
• Age‐specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta‐analysis

  2016cites this paper
• CYB5D2 displays tumor suppression activities towards cervical cancer.

  2016cites this paper
• Matching intended use and type of HPV test in research and clinical practice

  2015cites this paper
• The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients

  2015cites this paper
• Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells

  2015cites this paper
• Prognostic Implication of Human Papillomavirus Types and Species in Cervical Cancer Patients Undergoing Primary Treatment

  2015cites this paper
• Metastatic Squamous-Cell Carcinoma of the Lung Arising in a 12-Year-Old Boy with Juvenile Recurrent Respiratory Papillomatosis of Neonatal Onset

  2014cites this paper
• Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand

  2014cites this paper
• An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain

  2014cites this paper
• Ectonucleotidase expression profile and activity in human cervical cancer cell lines.

  2014cites this paper
• Tissue biomarkers as prognostic variables of cervical cancer.

  2013cites this paper
• Prevalence and Distribution of High-Risk Human Papillomavirus Genotypes in Invasive Carcinoma of the Uterine Cervix in Uruguay

  2013influential citation
• Chapitre 7 – Biologie des cancers génitaux de la femme

  2013cites this paper
• папилломавируСная инфеКция ONCOTROPIC PAPILLOMAVIRUS INFECTION AND PROGNOSIS FOR PATIENTS WITH CERVICAL CANCER

  2013cites this paper
• HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3.

  2012cites this paper
• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns

  2012cites this paper
• Le PAIR-gynécologie : recherche multi/interdisciplinaire en cancérologie gynécologique. Les problèmes à résoudre en 2012

  2012cites this paper
• [PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved].

  2012cites this paper
• Uterine cervix carcinoma: recent biological data and update for improving follow-up and treatment.

  2012cites this paper
• Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology.

  2012cites this paper
• Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.

  2011cites this paper
• Characterization of a cluster of oncogenic mutations in E6 of a human papillomavirus 83 variant isolated from a high-grade squamous intraepithelial lesion.

  2011cites this paper
• HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study

  2011cites this paper
• HPV types in early-onset cervical cancer.

  2011cites this paper
• An investigation cervical cancer, human papillomavirus (HPV) infection and steroid contraception

  2011cites this paper
• High-Risk HPV DNA Testing and HPV-16/18 Genotyping: What Is the Clinical Application?

  2011cites this paper
• The Importance of HIV Status and Gender When Designing Prevention Strategies for Anal Cancer

  2011cites this paper
• Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma

  2010cites this paper
• HPV genotypes: implications for worldwide cervical cancer screening and vaccination

  2010cites this paper
• HPV genotypes: implications for worldwide cervical cancer screening and vaccination.

  2010cites this paper
• Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

  2010cites this paper
• eview pproaches to monitoring biological outcomes for HPV vaccination : hallenges of early adopter countries

  2010cites this paper
• Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy.

  2010cites this paper
• Region-Wise Distribution of High-Risk Human Papillomavirus Types in Squamous Cell Carcinomas of the Cervix in India

  2010cites this paper
• Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

  2009cites this paper
• Fixed-dose chloroquine and sulfadoxine/pyrimethamine treatment of malaria : Outcome and pharmacokinetic aspects

  2007cites this paper
• Genotyping of Human Papilloma Virus (HPV) in Cervical Cancer at the Federal Teaching Hospital Ido-Ekiti, Ekiti State, Nigeria

  year unknowninfluential citation